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The inhibitory effect of peptone upon the bacteriostatic and bactericidal 
action of sulfanilamide was described by Lockwood (1).  It was postulated 
that  sulfanilamide  may  act  upon  microorganisms  by  preventing  their 
utilization  of  protein-split  products,  and  that  peptone  provided  easily 
assimilable  nitrogen in  such  excess  that  the  bacteriostatic  effect of  sul- 
fanilamide is decreased (2).  Lockwood and Lynch (2)  have recently ex- 
tended this concept to explain the diminution of activity of sqlfanilamide 
in the presence of purulent exudates, since under such circumstances the 
end-products of protein digestion may accumulate and interfere with the 
baeteriostatic action of the drug.  Stamp  (3)  has described the presence 
of  an  inhibitory  substance  in  hemolytic streptococci,  and  has  partially 
purified inhibitor-containing extracts of these cells.  Similarly,  Green  (4) 
has shown that an inhibitory substance may be extracted from organisms 
of the BruceUa group, and Fleming (5) has demonstrated the presence of a 
sulfonamide inhibitor in  heavy  suspensions of  staphylococcus, Bacterium 
aertrycke,  Streptococcus viridans,  and  Streptococcus pyogenes. 
The occurrence of  the  sulfonamide inhibitors is  of  importance  in  an 
understanding of the mode of action of this group of drugs both in vitro 
and in the animal body.  For this reason a  study has been made of the 
distribution of inhibitors in  animal tissues and fluids,  as well as  in bac- 
teriological media and bacterial cultures. 
In order to test accurately for the presence of sulfonamide inhibitors it 
is necessary to use a culture medium which is free of these substances, and 
to  choose  an  organism  which  will  grow  optimally  in  such  a  medium. 
Bacterium coli fulfills these requirements since it will grow luxuriantly in an 
inhibitor-free medium consisting of simple salts to which glucose is added 
as a source of carbon, and asparagin as a source of nitrogen.  Sulfanilamide 
* Read at the 32nd Annual Meeting of the American Society for Clinical Investigation, 
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and  sulfapyridine  exert  a  pronounced  bacteriostatic  effect  upon  B.  coli 
in  this  medium.  Materials  to  be  tested  for  the  presence  or  absence  of 
sulfonamide  inhibitor  may be added,  and  their  effect determined  more or 
less  quantitatively.  Moreover,  the  strain  of B.  coli used  in  these  experi- 
ments  produces  relatively  little  inhibitor,  so  that  the  sensitivity  of  the 
test  is  therefore  much  increased. 
In  the  present  paper  the  occurrence  of  a  substance  or  substances  in- 
hibiting  the  bacteriostatic  effect  of  the  sulfonamide  drugs  is  described. 
It will  be shown  that  the  inhibiting  substances occur in many but not  all 
protein hydrolysates and that they are also present in certain normal body 
tissues.  Furthermore,  they  have  been  found  in  sterile  serous  effusions, 
and  are present  uniformly in  normal  urine,  although  in  this  instance  the 
inhibitory  effect  is  readily  demonstrable  only  after  hydrolysis. 
Materials and Methods 
Method of Testing for Presence or Absence of Sulfonamide  Inhibltors.--Tests for the 
presence or absence of sulfonamide inhibitors were performed by observing the effect of 
different amounts of the various materials upon the growth of B. coli in an inhibitor-free 
synthetic medium.  To the medium was added an amount of sulfapyridine which in the 
absence of inhibitor,  was sufficient  to prevent the visible growth of the standard  in- 
oculum.  Growth was estimated by observing the presence or absence of gross turbidity 
after incubation for 24 hours at 37°C.  The synthetic medium to which sulfapyridine or 
the test material had not been added served as growth control in each experiment.  In 
the presence of small amounts of inhibitor, maximum growth did not usually take place 
within 24 hours, so that estimation of the amount of inhibitor present could be made not 
only on the basis of the volume of test material added, but also on the amount of growth 
present  at  the  end  of the  arbitrary test period.  Furthermore,  by varying the  con- 
centration of sulfapyridine, differences in the amount of inhibitor present could also be 
estimated. 
Sulfapyridine.--A  neutral  solution  of  sulfapyridine  was  added  to  the  synthetic 
medium.  The final concentration varied in different experiments, and is indicated in 
each protocol. 
Culture of B. coli.--A strain of B. coli in  the  smooth phase was used throughout. 
The stock culture was grown in the synthetic medium to which glycerol was added as a 
carbon source in place of glucose.  It has been found that the organisms may be main- 
tained in  the  smooth phase if cultivated in  a  glycerol-containing medium, whereas if 
glucose is used as the carbon source a mixed population of R  and S forms develops on 
repeated subculture.  The stock culture was stored in the ice box. 
Inoculum.--The  dilutions of the stock culture used in  the  tests were made in  the 
synthetic medium.  10  -4 cc. of culture was used to seed a volume of 5.0 cc. of culture 
fluid.  This dilution  contained  between  70,000 and  100,000 cells,  as  determined  by 
plate counts. 
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B. coli was that described by Sahyun, Beard, Schultz, Snow, and Cross (6), and con- 
tained the following ingredients: 
Ammonium sulfate ..........................................  4.72 gin. 
Asparagin ..................................................  2.0  " 
Sodium chloride ............................................  5.0  " 
Glucose ....................................................  2.0  " 
KH2PO4(M/5). ..............................................  100.0  CC. 
NaOH  (N/l)  ...............................................  16.4  " 
MgCls; FeCI2; CaCl~ (½ per cent mixture)  .....................  i  .0  " 
Distilled water ...........................................  to 1000  " 
The medium was sterilized in the autoclave; the pH was 7.6. 
In the latter part of the work a casein hydrolysate known to be inhibitor-free, was 
added in the proportion of 2 gin. per liter of medium.  The addition of the casein hy- 
drolysate ensured  an  optimum growth rate.  All readings of presence or absence of 
growth were made after 24 hours incubation at 37°C. 
In  the performance of bacteriostatic tests sulfapyridine in varying concentrations 
was added.  The volume of medium inoculated with B. coli was 5.0 cc. in all instances. 
This volume included both the sulfapyridine and the solution to be tested for sulfon- 
amide-inhibiting effect. 
Liver Infusion Medium.--In order to test for the occurrence of sulfonamide inhibitor 
in the cells and culture superuatants of certain pathogenic bacteria, it was necessary to 
use  an  inhibitor-free medium  which  would  support  growth  without  the  addition of 
peptone.  Infusions  of muscle  were  unsatisfactory both  because of  their  content  of 
inhibitor and also because growth of pneumococcus or Streptococcus  hemolyticus did not 
occur unless a large inoculum was used.  An infusion of fresh beef liver was found to be 
satisfactory, since it was free of inhibitor and supported the rapid and profuse growth of 
pneumococcus,  Streptococcus  hemolyticus,  and  staphylococcus  following  a  minimal 
inoeulum. 
Calf's liver was obtained at the slaughterhouse as soon as possible after the death of 
the animal, and the gall bladder removed intact.  The liver was placed immediately in 
boiling water for 5 to 10 minutes to destroy the autolytic ferments.  It was then minced 
in a meat grinder and suspended in twice its weight of tap water including that in which 
it had been boiled.  The pH was adjusted to 5.0 with HCI and the suspension heated 
in a  water bath.  The temperature was brought gradually to 80°C.,  at which it was 
maintained for  15  to  20 minutes.  The  supematant  fluid was  decanted and filtered 
through  coarse  paper  until  clear.  Mter  cooling to  room  temperature  solid sodium 
chloride was added to make a final concentration of 0.5 per cent and the pH adjusted to 
7.8 with NaOtt.  A fine flocculent precipitate usually formed at this time which was 
removed  by  filtration  through  paper.  The  clear,  fluorescent,  yellow  solution  was 
sterilized by passage through Pasteur-Chamberland candles after first warming it to 
35-40°C.  to  facilitate filtration. 
This medium is somewhat unstable if kept at room temperature, but is more stable if 
stored in the dark and in the ice box.  The addition in a final concentration of 2 per cent 
of either sterile ascitic fluid or fresh rabbit serum known to be inhibitor-free, was also 
found useful in stabilizing the growth-promoting properties of the medium. 220  OCCURRENCE  OF  SULFONAMIDE  INHIBITORS 
The content of reducing sugars in different lots of this medium varied  between  0.4 
and 0.5 per cent. 
It is important to use a culture medium which will support the optimum growth of the 
test organism since in a partially deficient medium the bacteriostatic effect of the sulfon- 
amide drugs is greatly enhanced.  Moreover, in a deficient medium the effect of materials 
containing a sulfonamide inhibitor may be extremely variable, since their action may be 
masked due to inadequate growth conditions. 
EXPER TM~NTAL 
Presence of Sulfonamide  Inhibitor in Bacteriological  Culture Media.--The 
common  bacteriological  media  used  for  the  cultivation  of pathogenic  or- 
TABLE  I 
Occurrence of Sulfonamide  Inhibitor  in Peptones and Casein Hydrolysates 
Peptone or casein hydrolysat¢ 
Difco--bacto-tryptone  ................................ 
"  proteose peptone .............................. 
"  bacto-peptone ................................. 
"  neopeptone ................................... 
Fairchild's peptone .................................... 
Pfanstiehl's peptone ................................... 
Witte's peptone ....................................... 
Casein hydrolysatc  enzymatic (Mead Johnson preparation 
No. 92Z38) ......................................... 
Casein hydrolysate--acid .............................. 
"  "  alkaline  ........................... 
Amount of prep- 
aration used 
mg. 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
Sulfonamide 
inhibitor 
+++ 
+++ 
+++ 
+++ 
+++ 
+++ 
Trace 
+++ 
Concentration  of  sulfapyridine:  1:20,000  in a  final volume of  5 cc.  of  synthetic 
culture  medium. 
Test organism: B. coti in the smooth phase. 
ganisms are prepared from infusions  of muscle or parenchymatous organs 
and enriched by the addition of peptone.  As originally noted by Lockwood 
(1) peptones are inhibitory to the bacteriostatic action of sulfanilamide on 
hemolytic streptococci.  It was of interest, however, to determine whether 
the  amount  of inhibitor  was  the  same in  various  brands  of peptone  and 
whether  sulfonamide  inhibitors  were present  in  protein  hydrolysates pre- 
pared  by methods other  than  enzymatic degradation. 
A  series of commercially available peptones was tested for the presence 
of  sulfonamide  inhibitors.  In  addition  enzymatic  and  acid  and  alkaline 
hydrolysates  of  casein  were  tested.  In  Table  I  the  content  of inhibitor 
in the various preparations is shown. 
All of the peptones tested showed the presence of sulfonamide inhibitor. 
The  enzymatic  digest  of  casein  contained  a  considerable  amount  of  the COLIN M.  MACLEOD  221 
active  substance,  but  hydrolysates  of  casein  prepared  by  heating  with 
concentrated acid or alkali were entirely free of inhibitor.  It would appear, 
therefore,  that  sulfonamide  inhibition  does not  depend  upon  the  presence 
of  easily  assimilable  nitrogen  since  the  acid  and  alkaline  hydrolysates  of 
casein supply a  great excess of nitrogenous substances and yet are entirely 
free of sulfonamide-inhibiting  action.  If an enzymatic casein hydrolysate 
which contains inhibitor is boiled under a  reflux condenser with either con- 
centrated  acid or alkali,  the inhibitor is destroyed,  although it is resistant 
to  boiling  in  dilute  acid or alkaline  solution. 
Presence of Sulfonamide  Inhibitor in Organs and Muscle.--The  presence 
of  sulfonamide  inhibitor  in  various  peptones  and  an  enzymatic  casein 
TABLE  II 
Occurrence of Sulfonamide Inhibitor in Extracts of Fresh and Autolyzed Tissues 
Tissue 
Skeletal muscle  ............. 
Heart muscle ............... 
Pancreas ................... 
Spleen ...................... 
c~ 
Liver ....................... 
~c 
Kidney ...................... 
Source 
Rabbit 
Beef 
Guinea pig 
Rabbit 
Beef 
Guinea pig 
Rabbit 
Sulfonamide inhibitor 
Fresh tissue  Autolyzed tissue 
+ 
+ 
++ 
+ 
+ 
++++ 
++++ 
++++ 
Concentration of sulfapyridine:  1:20,000  in a  final volume of 5.0 cc.  of  synthetic 
culture medium.  1.0 cc. of the various tissue extracts tested is included in this volume. 
Test organism: B. coli in the smooth phase. 
hydrolysate  and  its  absence from acid  or  alkaline  hydrolysates  suggested 
that the occurrence of this material is dependent upon enzymatic digestion. 
For  this  reason  extracts of fresh organs and  muscle from various species, 
as well as extracts of tissues which were permitted to autolyze under sterile 
conditions, were studied for the presence or absence of inhibitor. 
Various organs and muscle were obtained from normal animals immediately following 
death, and boiled in tap water for 10 minutes to destroy the autolytic ferments.  The 
boiled materials were minced in a meat grinder and extracted for 15 to 20 minutes in 
twice  their  weight of boiling  tap  water.  The filtered extract,  after the  addition  of 
NaC1 to 0.5 per cent concentration, was adjusted to pH 7.6 and sterilized by boiling. 
Minced fresh tissues suspended in  twice their weight of tap water were permitted to 
autolyze for 72 hours at 37°C.  Toluene was added to prevent bacterial contamination. 
The autolyzed material was boiled and filtered, and  the supernatant fluid tested  for 
inhibitor  after adjustment  of  the  salt  concentration  and  the  pH.  In  Table II the 222  OCCURRENCE  OF  SULFONAMIDE  INHIBITORS 
occurrence  of sulfonamide inhibitor in various fresh and autolyzed tissues of certain 
animals is shown. 
Extracts  of fresh  muscle,  pancreas,  and  spleen  as  shown  in  Table  II 
contained sulfonamide inhibitor.  Fresh liver from three different species 
was  entirely free of inhibitor,  however.  Rabbit  kidney extract likewise 
was inhibitor-free.  When autolysis had occurred under sterile conditions, 
the amount of inhibitor in extracts of muscle and pancreas showed a distinct 
increase, and the presence of the material could be demonstrated in auto- 
lyzed liver, although in the fresh state extracts of this tissue were entirely 
free of inhibiting effect. 
Inasmuch as  extracts of fresh muscle contain a  sulfonamide inhibitor, 
and since inhibitor is present also in peptones, it is obvious that the common 
bacteriological media which contain these two ingredients are unsatisfactory 
for  testing  the  bacteriostatic  action  of  sulfonamide  drugs.  The  widely 
divergent results of bacteriostatic tests reported by various workers might 
possibly be  due to  differences in  the  amount of inhibitor present in  the 
various lots of media used, particularly since the amount of inhibitor varies 
from one peptone to another and also since any autolysis of the muscle used 
as the basis of the meat infusion has been shown to increase the amount 
of inhibitor. 
The absence of the inhibiting material from extracts of fresh liver has 
proved  of great  advantage  in  that  a  bacteriological medium capable  of 
supporting the luxuriant growth of certain fastidious microorganisms can 
be made from this organ.  Pneumococci and hemolytic streptococci will 
grow readily in an infusion of fresh liver provided the infusion is not heated 
on the alkaline side.  The addition of peptone is unnecessary. 
Inhibitor-free liver infusion has been used as a  culture medium for the 
study  of  the  occurrence of  sulfonamide  inhibitor  in  bacteria  and  their 
growth products, and also to  determine the relative sensitivity of certain 
strains  of  microorganisms  to  sulfanilamide  or  sulfapyridine.  The  oc- 
currence of inhibitor in various bacterial cultures is described in a  subse- 
quent section of the present paper. 
Occurrence of Inhibitor  in  Body  Fluids.--The  observation  that  a  sul- 
fonamide inhibitor is present in fresh normal organs and tissues suggested 
the possibility that  a  similar substance might be present in  the fluids of 
the  body. 
Blood serum obtained during infection and in convalescence, and sterile 
effusions occurring in  serous cavities during various diseases were tested 
for  the presence or  absence of inhibitor.  The  results of these  tests  are 
shown in Table III. COLIN M.  MAcLEOD  223 
Sterile  blood  serum  obtained  from  a  total  of  sixteen  patients  ill  with 
various  diseases  in  no  instance  caused  inhibition  of  the  bacteriostatic 
effect of sulfapyridine under the conditions employed.  On the other hand, 
sterile pleural effusions from two of twelve patients with acute lobar pneu- 
monia  showed  the  presence  of  inhibitor,  t  Pleural  effusions  from  two 
patients  with  rheumatic  fever  contained  inhibitor  in  both  cases  and  in 
one  patient  suffering  from  chronic  heart  failure  complicated  by  facial 
TABLE III 
Occurrence of Sulfonamide  Inhibitor in Sterile Human Body Fluids 
Body fluid 
Blood serum 
Pleural fluid 
Pericardial fluid 
Peritoneal fluid 
Knee joint fluid 
Clinical diagnosis 
Acute lobar pneumonia 
Acute rheumatic fever 
Empyema 
Heart failure and erysipelas 
Carcinoma--mammary 
Acute lobar pneumonia 
Acute rheumatic fever 
Heart failure and erysipelas 
Tuberculosis--pulmonary 
Nephrosis 
Acute rheumatic fever 
Nephrosis 
Cirrhosis of liver 
Acute rheumatic fever 
b. of 
ses 
8 
2 
3 
1 
2 
No. of 
specimens 
16 
2 
3 
1 
2 
12 
2 
1 
1 
1 
No. of speci- 
mens showing 
presence of 
sulfonamlde 
inhibitor 
Concentration of sulfapyridine: 1:60,000  in a  final volume of 5.0 cc.  of synthetic 
culture medium.  1.0 cc. of the various fluids tested is included in this volume. 
Test organism:  B. coli in the smooth phase. 
erysipelas,  inhibitor  was  present  in  a  pleural  effusion.  Peritoneal  fluid 
from  a  patient  with  cirrhosis  of  the  liver  contained  inhibitor.  In  one 
patient with acute rheumatic fever, the pericardial fluid showed the presence 
of sulfonamide  inhibitor,  and  knee joint effusions obtained from four pa- 
tients with rheumatic fever all exhibited marked inhibitory action.  Peri- 
toneal  fluid  obtained  from  two  children  suffering  from  so  called  "lipoid 
nephrosis" did not cause sulfonamide inhibition. 
I We wish to thank Dr. Jesse G. M. Bullowa of Harlem Hospital, New York, for his 
generous assistance  in obtaining specimens of pleural effusions, and blood serum. 224  OCCURRENCE  OF  SULI~ONAMIDE  INI-IIBITORS 
It is of interest in relation to the data presented in Table III that serous 
effusions of the pericardium,  pleura, and knee joint occurring during rheu- 
matic  fever,  invariably  showed  the  presence  of  sulfonamide  inhibitor, 
whereas  only  two  out  of  twelve pleural  effusions occurring  during  lobar 
pneumonia  were  positive.  The  significance  of  these  findings  is  as  yet 
unknown. 
Occurrence of Sulfonamide Inhibitor in Pus.--In the previous experiments 
the occurrence of inhibitor in sterile effusions was determined.  In addition 
to these fluids, purulent  exudates occurring in  association with  a  number 
of infections have been tested.  In  all instances,  boiled,  cell-free extracts 
of pus have shown the presence of relatively large amounts of sulfonamide 
inhibitor.  Pus has been obtained from staphylococcal and pneumococcal 
abscesses, empyemas of the pleura due to pneumococcus and an anaerobic 
streptococcus  respectively,  and  in  one  case  from  pleural  empyema from 
which no microorganism could be recovered.  The presence of sulfonamide 
inhibitor  in  purulent  exudates  is  not  unexpected,  since  under  these  con- 
ditions  considerable autolysis occurs, and as shown previously in  the case 
of  normal  tissues,  the  amount  of  inhibitor  increases  greatly  during  the 
autolytic process. 
Occurrence of Sulfonamide Inhibitor in  Urine.--The  occurrence  of  sul- 
fonamide  inhibitor  in  certain  normal  tissues  and  its  absence  from  fresh 
liver,  fresh  kidney,  and  blood  serum,  suggested  the  possibility  that  the 
material  might  be excreted in  the  urine.  Urine  was  collected from  four 
normal  individuals  and  from  a  patient  suffering  from  empyema  of  the 
chest.  Care was taken to prevent bacterial contamination. 
The urine specimens were neutralized and boiled to ensure sterility.  A portion of 
each specimen of urine was made acid with HC1 in a final concentration of 0.2 N, placed 
in a narrow-necked flask to minimize contact with air, and boiled in a water bath for 
45 minutes.  The  hydrolyzed urine  specimens were neutralized,  and again boiled in 
order to sterilize them.  1.0 cc. portions of each specimen were used in testing for the 
presence or absence of sulfonamide inhibitor.  These data are presented  in Table IV. 
From  the  results shown in  Table  IV it would appear  that  most of the 
sulfonamide inhibitor  is conjugated in the body and excreted in the urine 
in  an  inactive  form.  Of  the  five  urines  tested  three  did  not  show  any 
inhibiting  effect until  acid  hydrolysis  of  the  urine  was performed.  The 
two specimens which contained only a  trace of inhibitor  before hydrolysis 
showed  a  marked  increase  after  hydrolysis. 
In addition to the above experiments with unconcentrated urine, in two 
instances concentrated urine was tested for the presence of inhibitor before 
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Urine  obtained from patients  1  and  2  (Table  IV)  was  concentrated fiftyfold  by 
evaporation in cellophane sacs suspended in a current of air.  The concentrated urines 
were treated with 10 volumes of acetone in order to precipitate the excess salts present. 
The supernatant acetone solutions containing  the inhibitor were taken down to dryness, 
and the dried material dissolved in water so that the final volume was one-fiftieth that 
of the original volume of urine.  The solutions were brought to pH 7.6 and sterilized by 
boiling.  A portion of each urine concentrate was then hydrolyzed in acid as described 
above for the unconcentrated specimens. 
The  concentrated  urines  were  tested  for  sulfonamide  inhibitor.  In 
both  cases  before  acid hydrolysis  1.0  cc.  of urine  concentrate,  equivalent 
to  50.0  cc.  of  urine,  did  not  cause  inhibition  of  sulfapyridine  1:20,000. 
TABLE IV 
Occurrence of Sulfonamide Inhibitor in Urine before and after Acid Hydrolysis 
Patient from whom urine was obtained 
1.  Empyema--sterile ........................... 
2.  Normal .................................... 
4.  ~  .................................... 
Sulfonamlde inhibitor 
Before acid hydrolysis 
J 
± 
4- 
After acid hydrolysis 
+++ 
+++ 
++-t- 
+++ 
++ 
Concentration of  sulfapyridine:  1:60,000  in a  final volume of 5.0 cc.  of synthetic 
culture medium.  1.0 cc. of urine is included in this volume. 
Test organism:  B. coli in the smooth phase. 
However, after acid hydrolysis 0.1  cc. of concentrate, equivalent to 5.0 cc. 
of  urine,  caused  complete  inhibition  of  sulfapyridine  1:20,000. 
The observation that  most of  the  sulfonamide  inhibitor  in  urine  is  ex- 
creted in a  conjugated form, suggested that the failure of liver and kidney 
extracts  to inhibit  might be  due  not to  the  absence of the inhibitor  from 
these  organs,  but  rather  to  its  presence  in  an  inactive,  conjugated form. 
To test  this  possibility the following experiments  were  carried out. 
Fresh rabbit liver  was boiled  to destroy the autolytic ferments.  A portion of the 
finely minced  tissue in tap water was brought to pH 1.5 by the addition of 4 N HC1. 
The other portion was kept at neutral reaction.  Both suspensions were heated in a 
boiling water bath for 45 minutes.  The pH was brought to 7.6 in each instance,  and 
the volumes adjusted with tap water so that the amount of fluid was equivalent to twice 
the original weight of tissue.  The suspensions were boiled again to ensure  sterility  and 
the liver tissue removed by centrifugation.  The supematant fluids were tested for their 
inhibiting  effect.  Fresh  rabbit  kidney  was  subjected  to  the  same  procedures  and 
similarly tested.  The results of these tests are shown in Table V. 226  OCCURRENCE  OF  SULI~ONAMIDF.  INI-I'IBITORS 
From the observations recorded in Table V it would appear that inhibitor 
is actually present in both fresh rabbit liver and kidney, but that in these 
tissues it occurs in an inactive, conjugated form, since its effect is demon- 
strable  only  after  hydrolysis.  It  is  possible  that  the  liberation  of  sul- 
fonamide inhibitor  during  autolysis  of  liver  may  be  due  to  enzymatic 
hydrolysis of conjugated inhibitor, in analogy to the release of the active 
form from liver  and  kidney upon  acid  hydrolysis.  However,  this  does 
not rule out the possibility that inhibitor may be actually formed during 
autolysis or that more of preformed, active inhibitor may be released during 
cell  breakdown  than  would result  from  extraction of  intact,  non-auto- 
lyzed cells. 
TABLE  V 
Occurrence of Sulfonamide Inhibitor in Fresh Rabbit Liver and Kidney  before and after 
A cid Hydrolysis 
Organ extract  i[ 
Rabbit liver ................................... 
kidney ................................. 
Sulfonamide inhibitor 
Be~re Mid hydrolysis  After a~d hy&ol~ 
-  ++++ 
-  ++++ 
Concentration  of sulfapyridine:  1:20,000  in a final  volume of 5.0 cc.  of synthetic 
culture medium.  1.0 cc. of the various tissue extracts is included in this volume. 
Test organism:  B. coli in the smooth phase. 
The finding of inhibitor in an inactive form in rabbit liver and kidney 
tissue  affords an  explanation for the occurrence of a  similar material in 
urine.  It seems likely that the inhibitor is conjugated in certain organs 
of the body and excreted in the urine in this form. 
Occurrence of Sulfonamide Inhibitor in Bacterial  Cullures.--The presence 
in  bacterial  cultures of substances inhibiting the bacteriostatic  action of 
sulfanilamide  or  sulfapyridine  has  been  described  by  several  workers. 
Stamp  (3)  extracted  hemolytic  streptococci  with  dilute  ammonia  and 
demonstrated the presence of an inhibitor in these ceils.  Partial purifica- 
tion  of  the  extracts  was  carried  out.  Similarly,  Green  (4)  employing 
Stamp's technique succeeded in  extracting  a  sulfonamide inhibitor from 
organisms of the Brucella group.  This he termed a  "pullulating factor" 
since some stimulation of bacterial growth occurred when partially purified 
extracts were added to bacterial cultures.  " In the opinion of this investiga- 
tor, the action of the inhibitor is due to non-specific stimulation.  Fleming 
(5)  has  described  the  inhibitory  effect  of  suspensions of  staphylococci, 
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effect is  due  to  the  liberation  of  some  substance  or  substances favoring 
bacterial  multiplication.  In  addition  to  these  observations  on  bacteria, 
Woods  (7)  and Woods  and Fildes  (8)  have extracted from brewers'  yeast 
an inhibitor of the sulfonamide drugs.  The properties of a  highly purified 
extract  suggested  to  Woods  and  Fildes  that  p-aminobenzoic  acid  might 
act  as  a  sulfonamide  inhibitor.  Tests  with  this  substance  showed  it  to 
have  a  powerful inhibiting  effect,  and  Woods  has  suggested  that  this  is 
the naturally occurring inhibitor present in bacteria and yeast.  We have 
confirmed the  observations  of  Woods  and  Fildes  on  the  annulling  effect 
of  p-aminobenzoic  acid  on  the  bacteriostatic  action  of  the  sulfonamide 
drugs.  Although  many  of  the  properties  of  the  naturally  occurring  in- 
hibitors are similar to those of p-aminobenzoic acid, it has been found that 
the  inhibitors  present  in  enzymatic  digests  of  casein  and  in  cultures  of 
pneumococcus differ in certain of their chemical properties from p-amino- 
benzoic  acid. 
The  occurrence  of  inhibitor  in  the  bacterial  cells  and  culture  super- 
natants of strains of four bacterial species has been studied.  The organisms 
used were B.  coli,  pneumococcus, staphylococcus, and  a  strain of Strepto- 
coccus  hemolyticus  belonging to the Lancefield group D. 
The cultures  of pneumococcus,  staphylococcus,  and  streptococcus group  D  were 
grown in liver infusion; B. coli was grown in the synthetic medium.  Both of these media 
are free of drug-inhibiting substances.  In the cases in which the supernatant was used 
the cultures were boiled in a water bath and the cells removed by centrifugation.  The 
supernatant liquid was brought to pH 7.6, 0.2 per cent dextrose was added, and the 
solution sterilized by boiling.  Where suspensions of bacteria were used, the living cells 
were collected by centrifugation, washed  twice in a large volume of M/15 phosphate 
buffer of pH 7.6, and resuspended in buffer.. The washed cells were then heated in a 
boiling water bath.  In addition to heat-killed pneumococci it was possible to test the 
inhibitory effect of washed  suspensions  of living pneumococci,  since this organism  is 
unable to multiply in the synthetic medium used for growing the test organism,  B. coli. 
Furthermore, suspensions of living pneumococci  were allowed to autolyze for 48 hours 
at pH  7.6 until only Gram-negative debris  remained, and the clear autolysate after 
boiling was tested for inhibitory effect.  Suspensions of living B. coll and the strain of 
streptococcus group D  were  extracted according to Stamp's method with N/25  am- 
monium hydroxide for 72 hours at 37°C.  The extracts were centrifuged and the super- 
natants taken to dryness in a vacuum flask, dissolved in a small volume of water, brought 
to pH 7.6, and boiled.  The drug-annulling  effect of these preparations was tested by 
adding them to the synthetic medium containing sulfapyridine.  B. coli was used as the 
test organism.  The results of these experiments are shown in Table VI. 
The data in Table VI demonstrate that in the various bacterial species 
the  sulfonamide  inhibitor  shows  differences  in  its  distribution  between 
the  bacterial  bodies  and  the  culture  fluid  in  which  the  cells  have  been 228  OCCURRENCE OF  SULFON.AMmE INHIBITORS 
grown.  In the case of B.  coli grown on the synthetic medium, inhibitor 
is  apparently restricted  to  the  cells  themselves and  does not  diffuse ap- 
preciably into the culture medium.  Although washed, heat-killed B.  coli 
do not cause inhibition, the presence of inhibitor in the cells can be demon- 
strated in  extracts obtained by treating  them with dilute ammonia.  In 
TABLE  VI 
Occurrence of Sulfonamide Inhibitor in Bacterial Cells and Culture Supernatants 
Bacterium 
5. coli 
Culture  media*  Portion of culture tested 
Amountof 
material 
used in 
terms of cc. 
of original 
culture 
Synthetic  Supematant  5.0 
Cells: 
1.  Heat-killed  25.0 
2.  Extracted with N/25  150.0 
NI-hOH 
~tapltylococvus  Liver  Supematant  1.0 
aurats  infusion  Cells: 
Heat-killed  30.0 
Pneumococcus  Liver  Supernatant  1.0 
Type I  infusion  Cells: 
1. Living  7.5 
2. Heat-killed  7.5 
3. Autolyzed  75.0 
3treptococcus  Liver  Supernatant  1.0 
group D  infusion  Cells: 
(Lancefield)  1. Heat-killed  30.0 
2.  Extracted with N/25  150.0 
NH,  OH 
Concentra- 
tion of sul-  Sulfonamide 
fapyridlne  inhibitor 
1:60,000 
1:60,000 
1:20,000  -4-+++ 
1:60,000  ++++ 
1:60,000 
1:60,000  ++ 
1:20,000 
1:20,000 
1:20,000 
1:60,000 
1:60,000  ++ 
1:20,000  ++ 
The final volume of synthetic culture medium used was 5.0 cc. in each instance. 
Test organism: B. coli in the smooth phase. 
* The culture media used to grow the four strains of bacteria were free of inhibitor 
before inoculation. 
the case of the strain of streptococcus group D,  a naturally occurring sul- 
fonamide-resistant strain,  the  inhibitor is  likewise restricted  to  the  cells 
and the supernatant is free of inhibitor under the conditions of these ex- 
periments.  On the other hand, Staphylococcus  aureus  and Pneumococcus 
Type I  released into the medium amounts of inhibitor which were easily 
demonstrable, whereas  the  cells  themselves were  inhibitor-free.  Extrac- 
tion of the cell bodies with dilute ammonia was not carried out in these 
instances.  It is of interest that suspensions of washed, living pneumococcal COLIN  M. MAcLEOD  229 
ceils did not produce inhibitor in a medium in which this organism is unable 
to grow, and that the completely autolyzed cells from a  large volume of 
culture  were  free  of  inhibitor. 
Difference  in  the  Amount  of Sulfonamide  Inhibitor  Produced  by  Sulfa- 
pyridine-Susceptible and Sulfapyridine-Fast Strains of Pneumococcus Type I. 
--We  have  described previously certain  alterations  which take place in 
cultures of Pneumococcus Type I  upon the acquisition of fastness to sulfa- 
TABLE  VII 
Comparative Amounts of Sulfonamide Inhibitor in Cultures of Parent and 
Sulfapyridine-Fast Strains of Pneumococcus Type I Grown in 
Inhibitor-Free Liver Infusion Medium 
Ameunt of 
material used  Concentration  Sulfonamide 
Strain of Pneumococcus Type I  Portion of culture tested  in terms of cc.  of original  of sulfapyridlne  inhibitor 
culture 
Parent strain  Supernatant 
Sulfapyridine-fast strain 
Parent strain 
Sulfapyridine-fast strain 
Supernatant 
Cells: 
1.  Living 
2.  Heat-killed 
3.  Autolyzed 
Cells: 
1.  Living 
2. Heat-killed 
3.  Autolyzed 
1.0 
0.6 
0.2 
1.0 
0.6 
0.2 
7.5 
7.5 
75.0 
7.5 
7.5 
75.0 
1:60,000 
1:60,000 
1:60,000 
1:60,000 
1:60,000 
1:60,000 
1:20,000 
1:20,000 
1:20,000 
1:20,000 
1:20,000 
1:20,000 
++ 
++++ 
++++ 
++++ 
B 
± 
The final volume of culture medium was 5.0 cc. in each instance. 
Test organism: B. coli in the smooth phase. 
pyridine (9).  These changes include a  greatly diminished production of 
hydrogen peroxide on the part of the sulfapyridine-fast strain,  as well as 
a  diminution in the activity of its dehydrogenase systems toward glycerol, 
lactate,  and  pyruvate.  No  change  in  type  specificity or  virulence  ac- 
companied  the  metabolic  alterations.  It  was  of  interest  to  determine 
whether or  not  the  sulfapyridine-fast strain  differs from  the  susceptible 
parent strain in the production of sulfonamide inhibitor.  Cultures of the 
two strains of Pneumococcus Type I  were grown in the liver infusion me- 
dium.  The  bacterial  cells  and  supernatant  culture medium were  tested 
for inhibitor.  The results of these tests are shown in Table VII. 230  OCCURRENCE  Ole SULFONAMIDE  INHIBITORS 
The results shown in Table  VII make it  clear that  the acquisition of 
sulfapyridine fastness by a strain of Pneumococcus Type I  is accompanied 
by  a  great  increase  in  the production of sulfonamide inhibitor.  1.0  cc. 
of supernatant of the parent culture inhibits only partially the bacterio- 
static effect of sulfapyridine in a concentration of 1:60,000 whereas 0.2 cc. 
of  culture  supernatant  of  the  fast  strain  completely inhibits  the  same 
concentration of sulfapyridine.  The cell bodies of the two strains of pneu- 
mococcus do not differ significantly in  their  inhibiting effect.  Whether 
the  increased  amount  of  sulfonamide inhibitor  produced  by  the  sulfa- 
pyridine-fast strain is causally related to the various other metabolic changes 
previously described (9) is not known.  An understanding of this relation- 
ship  must  await  more  complete analysis  of  the  metabolism of  the  two 
strains of pneumococcus. 
DISCUSSION 
The widespread  distribution of a substance or substances which annul 
the bacteriostatic  action  of the sulfonamide drugs is  of  importance not only 
in relation  to the use of these chemotherapeutic agents in the treatment 
of infections  but also  in relation  to the mode of action of the drugs upon 
bacterial  cells  in vitro.  In an important contribution  to this  subject  Woods 
(7)  has demonstrated that p-aminobenzoic acid annuls the bacteriostatic 
effect of sulfanilamide in vitro, and that the inhibition is not due to a mo- 
lecular reaction between p-aminobenzoic acid and  sulfanilamide.  Woods 
has  postulated  that  p-aminobenzoic acid  is  essential  for  the  growth  of 
bacteria,  and  that  sulfanilamide  causes  bacteriostasis  by  inhibiting  the 
enzyme reaction involved in  the utilization of p-aminobenzoic acid.  As 
a  corollary to  this  theory,  Woods has  suggested that  differences in  the 
sensitivity of bacteria to sulfanilamide may be due to quantitative differ- 
ences in their ability to  synthesize p-aminobenzoic acid.  Selbie (10)  has 
shown  that  p-aminobenzoic  acid,  administered  by  mouth,  inhibits  the 
curative action of sulfanilamide in  experimental infections of mice with 
group A hemolytic streptococci. 
Certain  of  the  properties  of  the  sulfonamide inhibitors  occurring  in 
enzymatic hydrolysates of  casein and in culture supernatants of pneumo- 
coccus  are  similar  to  those  of  p-aminobenzoic acid.  However,  an  im- 
portant difference exists in their solubilities in acid ether,  p-Aminobenzoic 
acid may be extracted readily by ether from aqueous solutions at pH values 
below 4.5.  However, the inhibitors from  these natural  sources are only 
slightly extractable  under the same  conditions.  Woods has pointed out 
that novocaine, which is the hydrochloride of the p-aminobenzoic ester of 
N-diethyl-amino-ethyl alcohol [H,N. CeH~. CO. OCH2. CH~N(C2H6),] is also COLIN  M.  MAoLEOD  231 
a very potent sulfonamide inhibitor.  In respect to solubility in acid ether, 
novocaine behaves somewhat similarly to the inhibitors from casein digests 
and pneumococcal cultures in that it is only slightly soluble.  This is to 
be  expected  since  the  esterification  of  p-aminobenzoic acid  removes its 
acidic properties.  According to Woods the inhibitory effect of novocaine 
is slightly delayed, hence it may be possible that hydrolysis of the ester 
linkage is necessary before this compound becomes active.  This investi- 
gator has  stated that the properties of p-aminobenzoic acid and  the in- 
hibiting material obtained from yeast show many similarities.  However, 
he is of the opinion that the yeast factor may be different from p-amino- 
benzoic acid, although its structure and properties are similar. 
In the present paper the occurrence of active inhibitors in certain normal 
animal tissues is described.  It is also shown that in rabbit liver and kidney 
tissue and in human urine, most of the inhibitor is present in a conjugated 
form  so  that  its  activity  becomes  evident  only  after  acid  hydrolysis. 
Harrow, Power, and Sherwin (11)  have shown that when p-aminobenzoic 
acid is fed to either man or rabbit, part of it is excreted as p-acetylamino- 
benzoic acid.  In a later paper Harrow, Mazur, and Sherwin (12)  suggest 
that in addition to the excretion of an acetyl derivative of p-aminobenzoic 
acid,  a  portion may also be  excreted as  a  glucuronate.  In  the present 
study the finding of an inactive, conjugated derivative of the sulfonamide 
inhibitor in  rabbit  kidney, liver,  and in human urine,  suggests that  the 
inhibitor is handled by  the body in  a  manner similar to  that by which 
p-aminobenzoic acid is metabolized. 
Whatever  the  nature  of  the  substance  or  substances  responsible  for 
sulfonamide inhibition,  their  importance in  relation  to  the  therapeutic 
use of the sulfonamide drugs should be borne in mind.  The presence of 
an inhibitor in many of the tissues and fluids of the body as well as in as- 
sociation with the invading bacteria affords an explanation for the occur- 
rence of localized lesions, resistant to the action of the sulfonamide drugs, 
which may develop during the course of therapy even though necrosis or 
cell  autolysis  is  not  demonstrable.  Thus for example, it is conceivable 
that  empyema may be  more likely to  develop during the  treatment of 
pneumococcal pneumonia with sulfapyridine if an initially sterile effusion 
contains sulfonamide inhibitor, than if such an effusion is free of inhibitor. 
In  the  study of the  effect of the sulfonamide drugs upon bacteria  in 
vitro,  it is important that  a  medium initially free of inhibitor should be 
used,  otherwise  comparison of  the  results  of  different experiments with 
the same test organism is not possible.  The commonly used bacteriological 
media are not satisfactory since both the peptone and tissue infusion used 
in their preparation are known to vary from lot to lot in their content of 232  OCCURRENCE OF  SULFONAMIDE INHIBITORS 
inhibitor.  Moreover, different strains of the same bacterial species may 
vary in their susceptibility to the sulfonamide drugs, andas hasbeen shown 
in the case of Pneumococcus Type I a greatly increased amount of inhibitor 
is  produced when  sulfapyridine fastness  develops. 
SUM_MARY 
Sulfonamide inhibitor has been demonstrated in extracts of fresh normal 
muscle, pancreas, and spleen of certain  animals.  When autolysis of tis- 
sues takes place the amount of inhibitor is greatly increased. 
Fresh liver from beef, rabbit,  and guinea pig is free of active inhibitor, 
although inhibitor is  demonstrable in  autolysates  of  this  tissue.  Fresh 
rabbit kidney is likewise free of active inhibitor.  Following acid hydrolysis 
extracts of fresh rabbit liver and kidney cause sulfonamide inhibition. 
Normal human urine contains little or no active inhibitor.  However, 
upon acid hydrolysis, inhibitor is uniformly present. 
Sulfonamide inhibitor is present in some, but not all,  sterile serous ef- 
fusions occurring during certain diseases.  Inhibitor was found uniformly 
in pus.  None was found in blood serum. 
In certain species of bacteria the inhibitor is found in the cells only and 
is not demonstrable in the culture medium, whereas in other species, the 
inhibitor is found in the culture supernatant, and the cells themselves are 
relatively free. 
The development of sulfapyridine fastness in a  strain of Pneumococcus 
Type I  is accompanied by a  greatly increased production of sulfonamide 
inhibitor. 
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